Erlotinib: a new therapeutic approach for non-small cell lung cancer

P Bonomi - Expert opinion on investigational drugs, 2003 - Taylor & Francis
Although treatment with cytotoxic agents has produced modest survival improvement in
patients with stage III and IV non-small cell lung cancer (NSCLC), it appears that a plateau …
被引用次数：126 相关文章

[引用][C] a new therapeutic approach for non-small cell lung cancer

E BP - Expert Opin Investig Drugs, 2003 - cir.nii.ac.jp

Erlotinib: a new therapeutic approach for non-small cell lung cancer.

P Bonomi - Expert Opinion on Investigational Drugs, 2003 - europepmc.org
Although treatment with cytotoxic agents has produced modest survival improvement in
patients with stage III and IV non-small cell lung cancer (NSCLC), it appears that a plateau …

Erlotinib: a new therapeutic approach for non-small cell lung cancer

P Bonomi - Expert opinion on investigational drugs, 2003 - pubmed.ncbi.nlm.nih.gov
Although treatment with cytotoxic agents has produced modest survival improvement in
patients with stage III and IV non-small cell lung cancer (NSCLC), it appears that a plateau …